Carlo Briguori

Showing 1-11 of 11 articles

Coronary interventions

Observational multicentre registry of patients treated with IMPella mechanical circulatory support device in ITaly: the IMP-IT registry

Chieffo A, Ancona M, Burzotta F, Pazzanese V, Briguori C, Trani C, Piva T, De Marco F, Di Biasi M, Pagnotta P, Casu G, Giustino G, Montorfano M, Pappalardo F, Tarantini G, Garbo R, Preti G, Nicolini E, Sclafani R, Colonna G, Mojoli M, Siviglia M, Denurra C, Caprioglio F

February 7, 2020 | 10.4244/EIJ-D-19-00428

Coronary interventions

Safety and efficacy of polymer-free biolimus-eluting stents in all-comer patients: the RUDI-FREE study

Sardella G, Stefanini G, Briguori C, Tamburino C, Fabbiocchi F, Rotolo F, Tomai F, Paggi A, Lombardi M, Gioffrè G, Sclafani R, Rolandi A, Sciahbasi A, Scardaci F, Signore N, Calcagno S, Mancone M, Chiarito M, Giordano A

September 20, 2018 | 10.4244/EIJ-D-18-00148

Coronary interventions

Final results of a self-apposing paclitaxel-eluting stent fOr the PErcutaNeous treatment of de novo lesions in native bifurcated coronary arteries study

Naber C, Pyxaras S, Nef H, IJsselmuiden A, Briguori C, Schlundt C, Wykrzykowska J, Eberli F, Möllmann H, Galatius S, Rieber J, Commeau P, van Geuns R, Bouchez D, Mudra H

June 20, 2016 | 10.4244/EIJY15M06_02

Interventions for valvular disease

RenalGuard System for the prevention of acute kidney injury in patients undergoing transcatheter aortic valve implantation

Visconti G, Focaccio A, Donahue M, Golia B, Marzano A, Donnarumma E, Ricciardelli B, Selvetella L, Marino L, Briguori C

April 8, 2016 | 10.4244/EIJV11I14A317

Cystatin C and risk of mortality among patients undergoing percutaneous coronary intervention

Angeli F, Verdecchia P, Savonitto S, Arraiz G, Zaninotto M, Broccatelli A, Cosma C, De Servi S, Sabino F, Briguori C, Ambrosio G, Cavallini C

November 20, 2015 | 10.4244/EIJY14M08_02

Coronary interventions

Dedicated stents for distal left main stenting

Grundeken M.J, Magro M, Gil R, Briguori C, Sardella G, Berland J, Wykrzykowska J, Serruys P

May 19, 2015 | 10.4244/EIJV11SVA29

One-year outcomes in 1,010 unselected patients treated with the PROMUS Element everolimus-eluting stent: the multicentre PROMUS Element European Post-Approval Surveillance Study

Thomas M, Birkemeyer R, Schwimmbeck P, Legrand V, Moreno R, Briguori C, Werner N, Bramucci E, Ungi I, Richardt G, Underwood P, Dawkins K

March 20, 2015 | 10.4244/EIJY15M01_07

How should I treat a patient with severe mitral regurgitation and acute decompensated heart failure?

Donahue M, Librera M, Visconti G, Focaccio A, Golia B, Napolitano G, Briguori C

January 22, 2015 | 10.4244/EIJV10I9A185

Simplifying clinical risk prediction for percutaneous coronary intervention of bifurcation lesions: the case for the ACEF (age, creatinine, ejection fraction) score

Biondi-Zoccai G, Romagnoli E, Castagno D, Sheiban I, De Servi S, Tamburino C, Colombo A, Burzotta F, Presbitero P, Bolognese L, Paloscia L, Rubino P, Sardella G, Briguori C, Niccoli L, Franco G, Di Girolamo D, Piatti L, Greco C, Petronio A, Loi B, Benassi A, Patti A, Gaspardone A, Frati G, Sangiorgi G

July 27, 2012 | 10.4244/EIJV8I3A55

Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design

Briguori C, Visconti G, Ricciardelli B, Condorelli G

April 20, 2011

Sheiban I, La Spina C, Cavallero E, Biondi-Zoccai G, Colombo F, Palmerini T, Marzocchi A, Tamburino C, Margheri M, Vecchi G, Sangiorgi G, Santarelli A, Bartorelli A, Briguori C, Vignali L, di Pede F, Ramondo A, Fantoni C, De Carlo M, Falsini G, Benassi A, Palmieri C, Filippone V, Sangiorgi D, De Servi S

February 25, 2010

Latest news

NEW ISSUE

Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …

February 19, 2021

Ahead of Print

MitraClip for a range of LV dysfunction and secondary MR

Stamatios Lerakis et al.

March 2, 2021

Editorial

Thrombolysis in ST-elevation myocardial infarction is not dead

Petr Kala et al.

March 2, 2021

SCOPE 2, COACT 1 year, FORZA, COMPARE CRUSH

(Thanks to the support of Biotronik)

February 28, 2021

Guidance Papers

Guidelines, consensus & position papers

August 28, 2020

JAA

This Week's JAA's: Impact of crossing strategy on CTO recanalisation outcomes and more...